Multiple sclerosis disease modifying therapies’ adherence and total medical or disease associated costs or inpatient events using Pharmacy Quality Alliance guidelines and MarketScan Commercial Claims and Encounters Database
Summary
Multiple sclerosis disease modifying therapies’ adherence can lead to lower medical costs (combined inpatient and outpatient) and fewer rates of hospitalization and shorter days stay.
DATE PUBLISHED
April 12, 2021
FORMAT
Poster
AUTHORS
Francis Staskon, Heather Kirkham, Kathleen Love